Ads
related to: amgen inc drugs
Search results
Amgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAmgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript January 31, 2023 Amgen Inc. misses on...
Amgen sues Novartis to block generic osteoporosis, bone cancer drugs
Reuters via Yahoo News· 1 year agoAmgen Inc sued Novartis AG's Sandoz in New Jersey federal court Monday, accusing Sandoz's proposed...
Amgen’s $27.8 Billion Horizon Takeover Allowed in FTC Accord
Bloomberg via Yahoo Finance· 9 months ago(Bloomberg) -- Amgen Inc. can move forward with its $27.8 billion takeover of Horizon Therapeutics...
Amgen says experimental obesity drug has promising durability
Reuters via Yahoo News· 2 years agoAmgen Inc's experimental obesity drug demonstrated promising durability trends in an early trial,...
Drug, Biotech Stocks' Q2 Earnings on Aug 4: LLY, AMGN & More
Zacks via Yahoo Finance· 2 years agoThis is the busiest week for the drug/biotech sector this earnings season. Overall, it has been a...
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Benzinga via Yahoo Finance· 1 year agoAmgen Inc (NASDAQ: AMGN) has reportedly sued Novartis AG's (NYSE: NVS) Generic arm Sandoz on...
Amgen says Lumakras cuts risk of lung cancer progression by 34%
Reuters via Yahoo Finance· 2 years agoAmgen Inc's Lumakras pill reduced the risk of disease progression in patients with advanced lung...
Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal
Reuters via Yahoo News· 2 years ago(Reuters) -Amgen Inc on Thursday agreed to buy ChemoCentryx Inc for $3.7 billion to gain access to a...
U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents
Reuters via Yahoo News· 1 year agoWASHINGTON (Reuters) -The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to...
Amgen's Q2 Sales Impacted By Lower Prices, Currency Headwind, Reaffirms FY22 Outlook
Benzinga via Yahoo Finance· 2 years agoAmgen Inc (NASDAQ: AMGN) posted Q2 revenues of $6.59 billion, +1% Y/Y, slightly beating the...
Ad
related to: amgen inc drugs